Investigation Overview
November 11, 2016 (Shareholders Foundation) - An investigation on behalf of investors in shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) was announced over potential breaches of fiduciary duties by certain officers and directors at Alexion Pharmaceuticals. The investigation by a law firm concerns whether certain Alexion Pharmaceuticals, Inc. directors breached their fiduciary d...
You must register (for free) or login to view the entire investigation.